• endocrine signalling;
  • ultradian rhythm;
  • pulsatile hormone secretion;
  • glucocorticoid hormones;
  • gonadotrophin-releasing hormone;
  • mathematical modelling


  1. Top of page
  2. Abstract
  3. Introduction
  4. Encoding glucocorticoid pulsatility
  5. Decoding GnRH pulsatility
  6. Concluding remarks
  7. Acknowledgements
  8. References

Ultradian pulsatile hormone secretion underlies the activity of most neuroendocrine systems, including the hypothalamic-pituitary adrenal (HPA) and gonadal (HPG) axes, and this pulsatile mode of signalling permits the encoding of information through both amplitude and frequency modulation. In the HPA axis, glucocorticoid pulse amplitude increases in anticipation of waking, and, in the HPG axis, changing gonadotrophin-releasing hormone pulse frequency is the primary means by which the body alters its reproductive status during development (i.e. puberty). The prevalence of hormone pulsatility raises two crucial questions: how are ultradian pulses encoded (or generated) by these systems, and how are these pulses decoded (or interpreted) at their target sites? We have looked at mechanisms within the HPA axis responsible for encoding the pulsatile mode of glucocorticoid signalling that we observe in vivo. We review evidence regarding the ‘hypothalamic pulse generator’ hypothesis, and describe an alternative model for pulse generation, which involves steroid feedback-dependent endogenous rhythmic activity throughout the HPA axis. We consider the decoding of hormone pulsatility by taking the HPG axis as a model system and focussing on molecular mechanisms of frequency decoding by pituitary gonadotrophs.


  1. Top of page
  2. Abstract
  3. Introduction
  4. Encoding glucocorticoid pulsatility
  5. Decoding GnRH pulsatility
  6. Concluding remarks
  7. Acknowledgements
  8. References

Rhythms are fundamental in nature and endocrine rhythms span time frames ranging from milliseconds to years. Many of these are organised by endogenous mechanisms, including the circadian (approximately 24-h period) cycles of many hormones that free-run under constant conditions (1), and even slower circannual (approximately yearly) endocrine rhythms that are maintained under photoperiodic clamping (2). Hormone secretion is also rhythmic over much shorter time frames, as illustrated by neuroendocrine systems where oscillators controlling neuronal membrane potential, with time frames of milliseconds to seconds, control the coordinated activity of hypothalamic neuronal networks. These characteristically secrete hormone releasing factors into hypophysial portal blood in a pulsatile fashion with ultradian (period < 24 h) time frames of minutes to hours, which in turn drive the secretion of hormones from the anterior pituitary with similar time frames. The pituitary hormones act on target tissues, including the adrenals and gonads, which synthesise and secrete glucocorticoid hormones and gonadal steroids in a pulsatile fashion. The magnitude of this pulsatile hypothalamic-pituitary target gland activity is modulated by slower rhythms. Inputs from the suprachiasmatic nucleus (SCN), for example, result in a circadian variation in glucocorticoid pulse amplitude. In addition to daily changes, reproductive hormones also show oestrus/menstrual temporal profiles as well as circannual cycles in seasonal breeders.

Oscillatory signals are well described for both intracellular and cell-to-cell communication in many biological systems (3). When compared with steady-state signalling, pulsatile signalling allows greater control, is more robust to degradation, and is generally more energy efficient (4). Moreover, pulsatile signalling provides target sites with a quiescent interpulse interval allowing target receptor recovery, and is therefore essential for maintaining tissue responsiveness (5). Pulsatile signals may also be more ‘information rich’ in the sense that pulse amplitude, pulse duration, pulse shape and interpulse interval can all theoretically provide information to the target cell, in comparison to amplitude alone provided by a steady-state input. Most importantly, pulsatile signalling permits not only amplitude, but also frequency modulation, and the potential advantage of this is amply illustrated by comparing the information provided by a black and white television image (where each pixel has a given signal amplitude) and a colour television image (where each pixel has a given frequency as well as amplitude).

Ultradian pulsatility underlies the secretion of most hormones (6). Despite this, in many neuroendocrine systems, the physiological implication of these rhythms and the mechanisms underlying their generation (encoding) and interpretation (decoding) at target cells are still unclear. Here, we begin to address both of these questions. Specifically, we have studied mechanisms within the hypothalamic-pituitary-adrenal (HPA) axis responsible for encoding glucocorticoid pulsatility. We review the ‘hypothalamic pulse generator’ hypothesis, and also discuss an alternative model for pulse generation that involves steroid feedback-dependent endogenous rhythmic activity throughout the HPA axis. We also consider the second question concerning the decoding of hormone pulsatility, taking the hypothalamic-pituitary-gonadal (HPG) axis as a model system and focussing on molecular mechanisms of frequency decoding by pituitary gonadotrophs.

Encoding glucocorticoid pulsatility

  1. Top of page
  2. Abstract
  3. Introduction
  4. Encoding glucocorticoid pulsatility
  5. Decoding GnRH pulsatility
  6. Concluding remarks
  7. Acknowledgements
  8. References

A pulsatile mode of signalling underlies the activity of the HPA axis, a system crucial for maintaining basal and stress-related homeostasis by regulating the circulating levels of vital glucocorticoid hormones (cortisol in man, corticosterone in rodents). Glucocorticoids govern a broad range of physiological functions, including the regulation of cardiovascular, metabolic, cognitive and immunological activity (7–10). The regulation of HPA activity depends on multiple inputs (Fig. 1). In the hypothalamus, the paraventricular nucleus (PVN) receives an indirect input from the SCN which regulates circadian variation in HPA activity, as well as afferent information from brainstem nuclei responding to physical stressors such as hypotension and inflammation, and from limbic areas of the central nervous system that respond to cognitive and emotional stressors (11). The PVN regulates corticotroph activity in the anterior pituitary via two neuropeptides [corticotrophin-releasing hormone (CRH) and arginine vasopressin (AVP)], which are released into the pituitary portal circulation and hence the anterior pituitary. Upon stimulation, corticotrophs secrete adrenocorticotrophic hormone (ACTH) into the general circulation, through which it accesses cells of the adrenal cortex initiating the synthesis and secretion of glucocorticoids.


Figure 1.  Glucocorticoid release is regulated by the hypothalamic-pituitary adrenal (HPA) axis. Neurones of the paraventricular nucleus (PVN) receive circadian signals from the suprachiasmatic nucleus (SCN), as well as information from brainstem nuclei responding to physical stressors, and from limbic areas of the central nervous system (CNS) that respond to cognitive and emotional stressors. These neurones project to the median eminence where they release corticotrophin-releasing hormone (CRH) and arginine vasopressin (AVP) into the portal blood. These peptides act on corticotroph cells in the anterior pituitary to secrete adrenocorticotrophic hormone (ACTH) into the general circulation, which in turn stimulates the synthesis and release of glucocorticoid hormones (CORT) from cells of the adrenal cortex. Glucocorticoids feed back at the pituitary and hypothalamus to inhibit ACTH and CRH/AVP secretion, respectively.

Download figure to PowerPoint

Glucocorticoid hormones act at target sites via their two cognate receptors [the glucocorticoid receptor (GR) and mineralocorticoid receptor (MR)], the expression of which is widespread in areas regulating HPA activity (12–14). The classical effect of glucocorticoids is via activation of their receptors that translocate to the nucleus acting as ligand dependent transcription factors binding to glucocorticoid response elements at promoter regions of glucocorticoid sensitive genes (15–18). In addition to these classic genomic effects, there has been considerable recent interest in rapid nongenomic mechanisms through which glucocorticoids can also act (19,20).

In the basal state, glucocorticoids are released in an ultradian pulsatile fashion from the adrenal cortex, which results in rapidly changing levels of hormone concentration observable in blood plasma (21–24) (Fig. 2), as well as within target tissues such as the brain (25,26). The classic circadian glucocorticoid rhythm, which peaks in the morning in man (27) and evening in the rodent (28), is the result of amplitude (and to a lesser extent frequency) modulation of the underlying ultradian rhythm (22,23,29–33). A particularly striking feature of glucocorticoid pulsatility is the appearance of a more distinct ultradian rhythm during the peak of the circadian cycle, which operates at a frequency of approximately one pulse per hour in rats (see shaded region 2 of Fig. 3). Variations in amplitude and frequency of the ultradian rhythm not only compose the circadian rhythm, but also characterise changes in HPA activity that occur during early life programming (34), chronic stress (35), lactation and ageing (36), and a number of other physiological and pathological conditions (37).


Figure 2.  Human data for adrenocorticotrophic hormone (ACTH) and cortisol from a healthy male sampled at 10-min intervals, adapted from (24). Concentration time series demonstrates strong concordance between rhythmic secretion of ACTH and cortisol, as well as a short time lag in ACTH-induced cortisol secretion.

Download figure to PowerPoint


Figure 3.  Different ways in which the hypothalamic-pituitary adrenal axis encodes glucocorticoid pulsatility. In region 1, where mean corticotrophin-releasing hormone (CRH) levels are low, glucocorticoid pulsatility may well reflect the irregular high-frequency fluctuations in CRH and other corticotrophin-releasing factors acting on the anterior pituitary. In region 2, higher mean levels of CRH drive on the anterior pituitary are sufficient to excite the intrinsic rhythmicity of the pituitary-adrenal loop, which gives rise to the more distinct approximately hourly rhythm in glucocorticoid secretion. CRH data are adapted from a previous study (51); glucocorticoid data adapted from a previous study (21). All data were obtained from male Sprague–Dawley rats.

Download figure to PowerPoint

The importance of glucocorticoid pulsatility resides in its ability to provide a digital signalling system that can respond rapidly to stress or changes in environmental conditions. A recent study by Stavreva et al. (38) clearly shows that the pattern of glucocorticoid presented to a tissue is critical for its transcriptional response, and this effect is seen both in vivo and in vitro. The details of the mechanisms underlying both genomic and nongenomic signalling of glucocorticoid hormones are beyond the scope of this review, but they not only act directly on multiple genes throughout the body, but also have major effects on the ‘clock genes’ and through them on circadian physiology (39,40).

Despite the significance of glucocorticoid pulsatility (36), surprisingly little is known about the mechanisms that encode this rhythm. Although the role of the SCN is well founded in regulating circadian HPA activity (41,42), evidence suggests it is not required for the generation of ultradian rhythmicity. Indeed, lesioning of the SCN completely abolishes the circadian glucocorticoid rhythm in both the adrenals and blood plasma (43–45), although it has little effect on the ultradian rhythm, which persists at amplitudes and frequencies comparable to those observed at the peak of the native circadian rhythm (E. Waite, personal communication). Furthermore, pulsatility in the HPA axis appears to be regulated independently of the ultradian rhythmicity found in other neuroendocrine systems. Glucocorticoids and luteinising hormone (LH) are both secreted in pulses with similar frequencies, for example, although their release is not concurrent (37).

Given the wealth of evidence showing that the circadian pacemaker resides within the hypothalamus (46), it is perhaps not surprising that it has also been assumed that the ultradian rhythm was the result of a hypothalamic neural pulse generator. We review this hypothesis, covering what we feel to be the most important experimental studies and go on to discuss recent developments from theoretical studies, which have led us to propose a new model for the encoding mechanisms of glucocorticoid pulsatility.

The ‘hypothalamic pulse generator’ hypothesis

Neural signalling to the anterior pituitary is encoded in the dynamic patterns of hypothalamic neuropeptides released into the portal circulation (47). Both in man and the rat, the major ACTH secretagogues are CRH and to a lesser extent AVP, although oxytocin, norepinephrine and epinephrine may modulate corticotroph activity (48). Moreover, CRH is the only corticotrophin-releasing factor known to regulate pro-opiomelanocortin gene expression in the rat (48). Whilst, CRH is also an important ACTH secretagogue in ovine species there is evidence to suggest that the predominant corticotroph secretagogue is AVP (49).

Push–pull perfusion studies of the median eminence in freely moving rats show that CRH follows an irregular pulsatile mode of secretion, with a frequency of approximately three pulses per hour (50). Interestingly, no significant difference is seen in CRH pulse frequency between the morning and evening, indicating a relatively steady frequency over the diurnal period (51). On the other hand, mean CRH concentration levels do vary significantly over the 24-h period, with evening concentration levels being almost two-fold greater than those of the morning (51). These increased levels result from the fact that mean pulse nadir and peak levels, as well as pulse amplitude, and to a lesser extent pulse duration, are all significantly higher in the evening (51).

An episodic mode of secretion for CRH and AVP has also been demonstrated in vivo in a number of other species under basal conditions (48). In the portal blood of unrestrained conscious rams, a pulsatile pattern of CRH and AVP secretion is evident (52), and measurement of AVP in the pituitary venous effluent of the unanesthetised horse also reveals an episodic secretory pattern (53). In conscious sheep also, both CRH and AVP display a pulsatile secretory pattern in the portal blood (54).

The regulatory oscillator(s) underlying the pulsatile mode of CRH secretion remains to be defined. It is certainly interesting to compare the pulses of CRH with the much more organised pulsatile secretion of gonadotrophin-releasing hormone (GnRH) into portal blood. GnRH and LH release has a relatively consistent frequency, which correlates well with organised increases in electrical activity in networks of GnRH-producing neurones (55). By contrast, the irregularity of episodic CRH secretion not only suggests a different underlying mechanism, but may also reflect an inability of CRH-producing neurones to effectively synchronise with one another in a coherent way (51).

ACTH pulsatility and its relationship to CRH

Given this episodic release of CRH, it was not surprising that pulsatile patterns of ACTH measured in blood plasma were also found in many species (4). What has been more surprising however, is that in most cases, the relationship between pulsatile neuropeptides and ACTH rhythmicity is far from straightforward.

In the rat, two ultradian ACTH rhythms are found simultaneously (56). Concentrations of ACTH in blood plasma display fast episodic bursts of variable amplitude that occur at a frequency of approximately three pulses per hour (so-called ‘micropulses’), as well as larger and more prolonged episodes of secretion that appear approximately every 1–2 h (we shall refer to this as ‘ultradian’). The two rhythms in ACTH are related in the sense that it is in fact the rhythmic variation in micropulse amplitude that makes up the slower ultradian rhythm (56).

Blockade of endogenous CRH by passive immunoneutralisation in the rat results in a significant reduction in micropulse amplitude without any effect on micropulse frequency (57), which could be attributed to the pulsatile release of other corticotrophin-releasing factors, an intrinsic rhythmicity of the corticotroph, or a combination of these factors (58). Moreover, blockade of endogenous CRH practically completely destroys the slower ultradian rhythm (57), which has prompted speculation that the slower ultradian rhythm in ACTH is driven by rhythmic secretion of CRH (57). However, there are currently no solid data that support this hypothesis. In fact, this hypothesis is actually contradictory to data on the frequency of pulsatile CRH measured in rats of the same strain (male Sprague-Dawley), which was three pulses per hour across the circadian cycle (50,51,59), and which clearly correlates well with the ACTH micropulse frequency.

In larger species, which allow for the simultaneous measurements of portal blood and blood plasma, a straightforward connection between pulsatile CRH/AVP and pulses of ACTH is also absent. In rams, for example, a clear relationship between portal levels of AVP/CRH and temporal patterns of ACTH is not seen (52). In sheep, a large proportion of CRH/AVP pulses are not followed by a significant rise in ACTH, and a significant number of ACTH pulses are not preceded by a pulse in CRH or AVP (54). Moreover, in sheep that have undergone surgical disconnection of the hypothalamus from the pituitary, pulsatility in ACTH and cortisol is maintained (60).

Taken together, of these diverse experimental studies highlight the lack of any clear causal relationship between changes in portal CRH concentrations and the ultradian rhythmicity of ACTH and glucocorticoid hormones. This suggests that the generation of HPA ultradian activity must involve other factors, presumably at a sub-hypothalamic level.

Network encoding of pulsatility

Some biological systems are endogenously rhythmic and oscillate under the influence of constant stimulation, or even in the absence of stimulation; such systems are often referred to as ‘pacemakers’ (61). In hepatocytes (liver cells), for example, continuous stimulation with physiological levels of AVP induces intracellular Ca2+ oscillations, the frequency of which increases with increasing concentrations of agonist (62). The endogenous rhythmicity of these systems finds its roots in the underlying regulatory mechanisms that govern the dynamics of that system (3), and these often involve some form of feedback, which may be positive and/or negative, nonlinear in nature, and is often time-delayed (3,61,63). Indeed, circadian time-keeping in neurones of the SCN is achieved through an intricate molecular circuitry involving ‘clock genes’ that take part in a complex regulatory network consisting of transcriptional and translational feedback loops (64). Feedback also underlies the generation of ultradian rhythmicity at the cellular level. For example, serum treatment of cultured cells induces oscillatory expression of the transcription factor Hes1 at ultradian frequencies (period approximately 2 h), which is the result of a negative feedback loop whereby Hes1 binds directly to regulatory sequences in the Hes1 promoter, thereby repressing transcription of its own gene (65). The network comprising the HPA axis also features some of the properties that are common to pacemaker circuitry. In particular, the anterior pituitary, PVN and higher centres are all targets for negative feedback by circulating glucocorticoids (66–69). In addition to feedback, delays are inherent in the HPA network, which arise from transmission times through the blood, as well as delayed response times.

The existence of pacemaker traits in the HPA network has prompted speculation that the generation of pulsatile glucocorticoid secretion is not necessarily a result of the neural pulse generator in the hypothalamus, but may actually arise from the complex network of excitatory and inhibitory interactions between CRH, ACTH and the glucocorticoids. This view is supported by a number of studies that have developed mathematical models characterising the dynamic interactions between HPA hormones (70–72). Most of these studies assume that feedback at the level of both the pituitary and the hypothalamus gives rise to the ultradian rhythm. If this were the case, then CRH, ACTH and glucocorticoids would all oscillate over the same time frame. However, there is no good evidence for this. Specifically, in the rat, the approximately hourly rhythm observed in ACTH (56) and corticosterone (22) is not observable in CRH during either the nadir or peak of the circadian rhythm (51) and, if glucocorticoid feedback at the hypothalamic level was important in generating ultradian rhythmicity, then removal of this feedback should ablate CRH pulsatility. However, in cultured explants of the macaque hypothalamus, the pulsatile release of CRH persists both in the presence and absence of glucocorticoids (73) and, in conscious rats, CRH pulsatility in the median eminence is maintained following adrenalectomy (59).

We have recently taken a mathematical approach to explore the encoding mechanisms underlying glucocorticoid pulsatility. Our mathematical model builds upon one describing dynamic interactions within the HPA axis (74), and focuses on the effects of nonlinear feedback of glucocorticoids mediated by GR at the level of the anterior pituitary. Furthermore, we incorporate the delayed response of glucocorticoid secretion following ACTH stimulation (75), which results from the lack of releasable pools of glucocorticoids and the need to synthesise the hormone before secretion.

Our theoretical results do not discount the possibility of a hypothalamic pulse generator but suggest that ultradian pulsatility in ACTH and glucocorticoids can also occur even in the absence of pulsatile input from the hypothalamus, providing that the mean levels of hypothalamic drive are within a certain range. Thus, for very low or high levels of constant hypothalamic stimulation, the mathematical model predicts a steady-state response in ACTH and glucocorticoid levels, whereas, for intermediate levels of hypothalamic drive, sustained oscillations in ACTH and glucocorticoid levels occur (76). These oscillations are born out of the excitatory–inhibitory loop formed by the interactions between the anterior pituitary and the adrenal gland. Implicit in this idea is that there is a close coupling between ultradian rhythms in ACTH and glucocorticoids, and there is indeed good experimental evidence supporting such a relationship (Fig. 2).

Although yet to be tested in vivo, it follows from our work that the HPA axis may have multiple ways of encoding glucocorticoid pulsatility (Fig. 3). During the nadir of the circadian rhythm, when mean CRH levels are low, our mathematical results suggest that fluctuations in ACTH and glucocorticoids most likely reflect the activity of episodic CRH and other corticotrophin-releasing factors. During the peak of the circadian cycle, however, when mean CRH levels are significantly higher, the theoretical model predicts that these higher mean CRH levels are sufficient to generate the endogenous hourly rhythm in ACTH and glucocorticoids, an intrinsic property of the pituitary-adrenal system (76).

Under both basal and nonbasal conditions, the HPA axis functions as a closed-loop control system, heavily influenced by negative feedback from circulating glucocorticoids. The regulation of pulsatility in the HPA axis likely involves a number of factors. The complex network of excitatory and inhibitory connections coupled with the pulsatile activity of hypothalamic-releasing factors renders the task of unravelling mechanisms regulating glucocorticoid pulsatility extremely difficult. Experimental studies have so far been unsuccessful in identifying either the mechanistic or anatomical origin of the ultradian rhythm. We have been able to demonstrate, using a mathematical approach, that glucocorticoid negative feedback at the level of the anterior pituitary may not just be important for the homeostatic regulation of optimal levels of ACTH and glucocorticoids, but also could actually be involved in generating ultradian HPA activity. The implications of this finding are that the pulsatile patterns of glucocorticoids that we observe in blood plasma may well reflect the integrated activity of pulsatile hypothalamic forcing on an endogenously rhythmic pituitary-adrenal system.

Decoding GnRH pulsatility

  1. Top of page
  2. Abstract
  3. Introduction
  4. Encoding glucocorticoid pulsatility
  5. Decoding GnRH pulsatility
  6. Concluding remarks
  7. Acknowledgements
  8. References

In the preceding sections, the HPA axis was used as a model system to consider physiological mechanisms generating pulsatile glucocorticoid signals. Recent work (38,77) has demonstrated that target cells are sensitive to the pattern of glucocorticoid to which they are exposed, although the molecular mechanisms used by cells to decode pulsatile glucocorticoid signals have not yet been extensively explored. Accordingly, we now focus on the HPG axis as a model system for exploring pulsatile signal decoding.

The neuroendocrine network regulating HPG activity has many similarities to that which mediates HPA activity. In particular, it too is characterised by an ultradian pattern of hormone secretion. The main role of the HPG axis is in regulating reproductive function. Following its release from the hypothalamus, GnRH acts via seven transmembrane region (7TM) receptors to stimulate the synthesis and secretion of LH and follicle-stimulating hormone (FSH) from gonadotrophs in the anterior pituitary. It acts via type I GnRH receptors (GnRHRs) to stimulate phospholipase C, activating protein kinases C (PKC) and mobilising Ca2+. This leads to activation of mitogen-activated protein kinase (MAPK) pathways and Ca2+ effectors such as calmodulin, mediating effects of GnRH on exocytotic gonadotrophin secretion, as well as on the expression of many genes including those for the gonadotrophin subunits (78–80). Following their secretion into the general circulation, LH and FSH act to mediate the control of gametogenesis and hormone secretion from the gonads. In a similar manner to regulation of the HPA axis, feedback mechanisms (involving gonadal steroids and proteins such as activins, inhibins and follistatins) influence GnRH secretion and/or GnRH action at the pituitary (81,82).

GnRH is synthesised in, and secreted from, a relatively small number (100 s) of hypothalamic neurones and has long been known to be secreted in brief pulses. GnRH pulse frequency varies under different physiological conditions. For example, it varies over the menstrual cycle with pulses on average every 6 h in mid- to late-luteal phases and every 90 min during follicular and early luteal phases (83). GnRH pulse frequencies are higher in rats and mice with physiological pulse intervals of 8–240 min (84). Importantly, GnRH effects on its target cells depend upon pulse frequency as illustrated by early studies showing that constant GnRH suppresses LH and FSH secretion, whereas the restoration of GnRH pulses restores gonadotrophin secretion (85). Changing GnRH pulse frequency is also the primary means by which the body alters its reproductive status during development, with an increase in GnRH frequency driving the increased gametogenesis and gonadal steroid production at puberty (86). Moreover, stimulation paradigm is crucial for therapeutic manipulation of this system because pulsatile stimulation with GnRH agonists is used to stimulate gonadotrophin secretion in assisted reproduction, whereas sustained treatment ultimately reduces gonadotrophin secretion and this underlies agonist efficacy against steroid hormone-dependent cancers (87).

Although frequency decoding is fundamental to the physiology and pharmacology of the HPG axis, the mechanisms are poorly understood. Most recent work has focused on effects of GnRH on expression of gonadotrophin subunit genes, which [in both gonadotrophs and LβT2 cells; a gonadotroph lineage cell line expressing GnRHR, beta subunit of luteinising hormone (LHβ) and beta subunit of follicle-stimulating hormone (FSHβ)] are sensitive to GnRH pulse frequency. Increasing GnRH pulse frequency to physiological levels increases its effects on LHβ, FSHβ and GnRHR expression but, as frequency is further increased to super-physiological levels, transcription is reduced (84,88–94). Computational models (95–101) lacking negative feedback show frequency-dependence but not bell-shaped frequency-response relationships (Fig. 4). Indeed, it is generally considered that such bell-shaped frequency-response relationships require feedback mechanisms that could include GnRHR down-regulation, induction of RGS (regulator of G-protein signalling)-2, inhibition of Ca2+ channels by the calmodulin-dependent G-protein Kir/Gem, or induction of MAPK phosphatases (MKPs). Rapid homologous receptor desensitisation can be excluded as a mechanism because type I mammalian GnRHR do not show this behaviour. They lack the C-terminal tails that mediate phosphorylation, arrestin binding and desensitisation of numerous other 7TM receptors (79,102–104). Alternative decoding mechanisms involve interplay between Egr-1 [an extracellular signal-regulated kinase (ERK)-activated transcription factor providing a down-stream readout for ERK activation] and a co-regulator (Nab-2) at the LHβ promoter. In this model, low GnRH pulse frequency causes transient Egr-1 expression, causing expression of Nab-2 that inhibits LHβ expression, whereas, at high pulse frequencies, more sustained increases in Egr-1 quench Nab-2 and increase LHβ transcription (105). For the FSHβ promoter, similar interplay between c-Fos and the co-regulator TG-interacting factor has been proposed to underlie preferential activation at low GnRH pulse frequency (82). Another possibility, suggested by Ciccone et al. (106), is that cAMP response element-binding protein and inducible cAMP early repressor (ICER) are important. In this model, high pulse frequencies preferentially induce ICER causing transcriptional repression by competing for a cAMP response element site in the FSHβ promoter (106).


Figure 4.  Frequency decoding mechanisms. (a) Possible responses to a square wave pulsatile stimulation with 5-min pulse duration and 120-, 60- or 30-min pulse intervals, eliciting sequential responses (1–3) in a simple vectorial signalling pathway (in which the pulsatile stimulus causes response 1, which causes response 2, which in turn causes response 3). With such pulsatile inputs, upstream responses may have rapid onset and offset, following the input in a process known as digital tracking (rows 1 and 2). However, downstream responses with slower kinetics may not have not returned to baseline before repeat stimulation and this can result in cumulative saw-tooth responses in a process known as integrative tracking (row 3). Integrative tracking can increase the efficiency of signalling and the differential kinetics at different response levels can underlie differences in frequency-dependence (110) as illustrated in (b). This shows the relationship between pulse frequency and responses calculated as the area under the curve for the input signal (A) or three sequential responses [B, C and D, which correspond to responses 1, 2 and 3 in (a)] in a vectorial signalling cascade, again using a 5-min stimulus (so that the maximal frequency of 12 pulses/hour is identical to continuous stimulation). Note that maximal activation of response b is only seen with continuous stimulation, whereas near maximal activation of response D occurs at one pulse/hour. Importantly, these processes can not alone explain the genuine frequency decoding (i.e. dependence on interpulse interval that is independent of cumulative pulse duration) that is evident in the bell-shaped frequency-response relationships for gonadotrophin-releasing hormone (GnRH) effects on gonadotrophin subunit and GnRH receptor (GnRHR) expression [i.e. all the curves in (b) reach the same maximum as pulse frequency increases]. Such frequency decoding is assumed to require positive or negative feedback or feedforward loops (96).

Download figure to PowerPoint

The results described above highlight three distinct possibilities: that GnRH frequency decoding reflects feedback effects on signal generation in the cytoplasm; that frequency decoding occurs at the level of the transcriptome; or that frequency decoding reflects both of the above. Using conventional techniques, it has been difficult to test the first of these possibilities, although we have developed live cell readouts for signalling pathways implicated in frequency decoding, and have used these to explore GnRH signalling, as outlined below.

We note here that it is important to distinguish between ‘frequency-dependence’ and ‘frequency-decoding’. There are many systems in which increasing pulse frequency increases responses but this could reflect either the increase in cumulative pulse duration or the reduction in interpulse interval (96). True frequency decoders sense interpulse interval independently of cumulative pulse duration (Fig. 4), as illustrated by GnRH effects on expression of genes encoding rodent LHβ and FSHβ, both of which are increased more effectively at low or intermediate GnRH pulse frequency than at high frequency or with sustained stimulation (84,88–94).

Nuclear factor of activated T-cells (NFAT) signalling

GnRHR-mediated activation of the Ca2+/calmodulin pathway can influence gonadotrophin subunit gene expression (107–109), and mechanisms by which calmodulins and their effectors interpret frequency-encoded Ca2+ signals are well established (110–113). More recently, NFATs, transcription factors activated by Ca2+/calmodulin-dependent activation of the protein phosphatase calcineurin (which dephosphorylates NFAT), have been implicated in transcriptional regulation by GnRH (114–116). This is of particular interest in light of the role of NFATs as frequency decoders in other systems (117–120). When GnRHR expressing HeLa cells were transduced with NFAT2-EFP (a reporter that translocates to the nucleus after Ca2+/calmodulin/calcineurin activation), GnRH caused dose-dependent NFAT2-EFP translocation, although the effect was slower than the underlying Ca2+ response (121). With pulsatile stimulation (5-min pulses, 1-h intervals), responses were reproducible with no measurable desensitisation or reduction in GnRHR expression. Varying the GnRHR number influenced response amplitude but not kinetics and, again, no desensitisation was seen. With 5-min GnRH pulses at 1- or 2-h intervals, the NFAT-EFP translocation responses returned to basal or near basal values between stimuli, so that the responses simply followed the stimuli (albeit with slower kinetics) in a process known as digital tracking (110). However, at high pulse frequency (30 min), responses had not returned to basal values before repeat stimulation and this led to cumulative of ‘saw-tooth’ responses, in a process known as integrative tracking. GnRH also caused dose- and frequency-dependent activation of αGSU-, LHβ- and FSHβ-luc reporters and these responses were inhibited by cyclosporin A (an inhibitor of calcineurin, the Ca2+/calmodulin sensitive phosphatase that causes NFAT translocation to the nucleus), indicating calcineurin-dependence. Pulsatile GnRH also activated an NFAT-responsive luc reporter, although its effect was proportional to cumulative pulse duration (121).

ERK signalling

Similar to many other 7TM receptors, GnRHR activate the Raf/MEK/ERK cassette (i.e. the basic components of the best characterised mitogen-activated protein kinase pathway, in which the protein kinase Raf phosphorylates and activates the protein kinase MEK causing it, in turn, to phosphorylate and activate ERK) (78–80). Activated ERKs can translocate to the nucleus where they phosphorylate transcription factors to control gene expression. GnRH activates ERK1/2, and ERKs can mediate GnRHR-stimulated transcription of the common αGSU subunit, as well as the LHβ and FSHβ (122–126). ERKs can mediate responses to pulsatile GnRH stimulation (107,127,128), pituitary-targeted ERK knockout can cause infertility (129), and the ERK cascade functions as a frequency decoder in other systems (130–132). To explore ERK signal dynamics, we developed a model in which small interfering RNAs (siRNAs) are used to prevent the expression of endogenous ERK1/2 and recombinant adenovirus are used to add back an ERK2-GFP reporter at a physiological expression level (133–135). With this system, we found that pulsatile GnRH causes dose- and frequency-dependent ERK2-GFP translocation to the nucleus. The responses were rapid and transient and therefore showed only digital tracking (Fig. 4). They also failed to desensitise under any condition tested (dose, frequency and receptor number varied). GnRH also caused dose- and frequency-dependent activation of an Egr1-responsive luc reporter (used as a downstream readout for ERK activation), although the responses were again proportional to pulse frequency (with no evidence of a bell-shaped frequency-response relationship). This response, similar to effects of pulsatile GnRH on FSHβ-luc, was inhibited by siRNA-mediated knockdown of endogenous ERKs (133). ERK responses are modulated by many ERK interacting proteins, including dual-specificity phosphatases (DUSPs), some of which can both scaffold and inactivate ERKs. Using siRNA to target DUSPs, we found that 12 of the 16 DUSPs expressed in HeLa cells influenced ERK responses to sustained stimulation with GnRH or a PKC activator (134,135). Moreover, GnRH can increase expression of nuclear-inducible MKP family DUSPs (125,136–138) and a recent computational model illustrated the potential for pulse frequency decoding by MAPK pathways and inducible phosphatases (98). Accordingly, we tested for effects of cycloheximide (to prevent nuclear-inducible MKPs induction), and used GFP fusions containing ERK mutations (D319N, which prevents D-domain-dependent binding of MKPs, and K52R, which prevents catalytic activity). These had little or no effect on the ERK translocation responses arguing against a role for MKPs or ERK-mediated feedback in shaping ERK activation (133).

Our data show that GnRH effects on the Ca2+/calmodulin/calcineurin/NFAT signalling and Ras/Raf/ERK signalling are frequency-dependent, and are consistent with roles for these pathways in mediating pulsatile GnRH effects on gonadotrophin expression. Nevertheless, these pathways do not appear to act as genuine frequency-decoders of GnRH signalling in the models used (HeLa and/or LβT2 gonadotrophs). We were unable to find evidence for the negative feedback assumed to underlie such frequency decoding (i.e. no desensitisation was seen and responses to pulsatile GnRH were not MKP-dependent) despite the fact that genuine GnRH frequency-decoding occurs in both models (121,133). These data differ from those obtained by using a mathematical model that predicts cellular responses to GnRH by simultaneous solution of differential equations describing various aspects of the GnRH signalling to LH secretion. Solving these nonlinear equations by machine computation predicts that GnRH effects will desensitise with pulsatile stimulation and that the extent of this desensitisation will increase with GnRH dose, frequency and receptor number (101,121), yet no such desensitisation was seen with either of our imaging assays. However, a reduction in cell surface GnRHR number is the primary cause of desensitisation in this computational model and we have found that a 5-min exposure to GnRH does not reduce cell surface GnRHR number in the HeLa cell model (121). To further explore this mathematically, we have adapted a published computational model for GnRHR signalling (101) by removal of receptor down-regulation as negative feedback mechanism and have extended it to incorporate two cellular compartments representing the cytoplasm and the nucleus, respectively. We couple both compartments by incorporating into the model the fluxes of activated/inactivated NFAT and ERK1/2 across the nuclear envelope. Thus, the model includes a number of time-dependent evolution equations for all the key players involved in GnRH signalling as outlined above. Accordingly, we have already calibrated preliminary model parameters using experimental measurements of the nuclear to cytosolic ratios of total NFAT (121) and ERK1/2 concentrations (133) as shown in Fig. 5. This model provides an excellent fit for the experimental data but, as noted above, digital or integrative tracking is seen with no evidence of adaptation that might underlie genuine frequency decoding, so we are currently extending the model to incorporate the action of NFAT and an ERK1/2-dependent transcription factor (e.g. Egr-1) as convergent inputs on GSU promoters.


Figure 5.  Modelling pulsatile gonadotrophin-releasing hormone receptors (GnRHR) signalling. Pulsatile stimulation for 5 min with varied GnRH pulse frequency at 30-min intervals, hourly intervals, or every 2 h, as indicated. (a) The data shown in the upper panel are the normalised nuclear to cytosolic (N : C) ratio of NFAT2-EFP fluorescence intensity (121). The bottom panel illustrated preliminary model simulations of the whole-cell model NFAT response. (b). The data shown are the N : C ratio of ERK2-GFP fluorescence intensity (Tsaneva-Atanasova K, Mina P, Caunt C, Armstrong S, McArdle C, unpublished data). The bottom panel illustrated preliminary model simulations of the whole-cell model ERK1/2 response (133). The data with GnRH at 1-h or 30-min intervals are offset by 1 or 2 units on the vertical axis for clarity.

Download figure to PowerPoint

Most of the previously developed mathematical models concentrate on a particular aspect of GnRH-signalling rather than on the system as a whole. Earlier theoretical work on modulation of pre-synthesised gonadotrophins was based on GnRHR desensitisation kinetics (97). Furthermore, LH release per se has been the focus of several theoretical studies where frequency-dependent modulation of secretion is a consequence of the presumed decrease in GnRHR plasma membrane expression (95,101). Most importantly, it is now clear that type I mammalian GnRHR do not undergo rapid desensitisation (103) and, although agonists do stimulate GnRHR trafficking (139), agonist-induced down-regulation of cell surface GnRHR was not seen with brief GnRH activation (121). Most work on GnRHR signalling has been with sustained stimulation paradigms so that signalling with physiological (pulsatile) activation remains relatively poorly understood, as does the mathematical basis for frequency decoding in this system. In this context, only one study (96) recapitulates experimentally-determined transcriptional characteristics of GSU synthesis; nonetheless, it reflects a ‘top-down’ approach by considering the complex GnRH-signalling as a ‘black-box’, subsuming this process within empirical assumptions regarding translational delays and putative GnRH network modules. There are very few computational models of transcriptional GSU gene regulation that have been developed from the ‘bottom-up’ approach, building on the wealth of knowledge for the intracellular pathways activated by GnRH. Ruf et al. (99) used single cell imaging to monitor effects of GnRH on ERK and down-stream transcriptional responses. However, their modelling concentrated only on the ERK1/2 pathway in populations of cells and did not take into account pulsatile GnRH stimulation. The effects of GnRH on the Ca2+/calmodulin/calcineurin/NFAT signalling and Ras/Raf/ERK signalling are frequency-dependant and can be regarded as sub-modules acting within the overall GnRH signalling pathway.

Concluding remarks

  1. Top of page
  2. Abstract
  3. Introduction
  4. Encoding glucocorticoid pulsatility
  5. Decoding GnRH pulsatility
  6. Concluding remarks
  7. Acknowledgements
  8. References

HPA and HPG axes are characterised by pulsatile hormone secretion and digital hormonal signalling systems. We have used these two model systems to demonstrate two major facets of neuroendocrine signalling: mechanisms by which they can encode signals, well exemplified in the HPA axis, and mechanisms by which cells in target tissues decode them, as described for the regulation of gonadotrophin secretion. Mathematical modelling has been key to elucidation of these signalling mechanisms, which highlights the power of modelling to investigate the organisation of complex neuroendocrine systems.


  1. Top of page
  2. Abstract
  3. Introduction
  4. Encoding glucocorticoid pulsatility
  5. Decoding GnRH pulsatility
  6. Concluding remarks
  7. Acknowledgements
  8. References

This work was supported by the Engineering and Physical Sciences Research Council (EPSRC) grant EP/E032249/1, and Wellcome Trust grants 084588 and 074112/Z/04/Z.


  1. Top of page
  2. Abstract
  3. Introduction
  4. Encoding glucocorticoid pulsatility
  5. Decoding GnRH pulsatility
  6. Concluding remarks
  7. Acknowledgements
  8. References
  • 1
    Maywood ES, O’Neill JS, Chesham JE, Hastings MH. Minireview: the circadian clockwork of the suprachiasmatic nuclei – analysis of a cellular oscillator that drives endocrine rhythms. Endocrinology 2007; 148: 56245634.
  • 2
    Lincoln GA, Clarke IJ, Hut RA, Hazlerigg DG. Characterizing a mammalian circannual pacemaker. Science 2006; 314: 19411944.
  • 3
    Goldbeter A. Biochemical Oscillations and Cellular Rhythms: the Molecular Basis of Periodic and Chaotic Behaviour. Cambridge: Cambridge University Press, 1996.
  • 4
    Gudmundsson A, Carnes M. Pulsatile adrenocorticotropic hormone: an overview. Biol Psychiatry 1997; 41: 342365.
  • 5
    Waxman DJ, Ram PA, Park SH, Choi HK. Intermittent plasma growth hormone triggers tyrosine phosphorylation and nuclear translocation of a liver-expressed, Stat 5-related DNA binding protein. Proposed role as an intracellular regulator of male-specific liver gene transcription. J Biol Chem 1995; 270: 1326213270.
  • 6
    Veldhuis JD, Keenan DM, Pincus SM. Motivations and methods for analyzing pulsatile hormone secretion. Endocr Rev 2008; 29: 823864.
  • 7
    Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995; 332: 13511362.
  • 8
    De Kloet ER, Joels M, Holsboer F. Stress and the brain: from adaptation to disease. Nat Rev Neurosci 2005; 6: 463475.
  • 9
    Herbert J, Goodyer IM, Grossman AB, Hastings MH, De Kloet ER, Lightman SL, Lupien SJ, Roozendaal B, Seckl JR. Do corticosteroids damage the brain? J Neuroendocrinol 2006; 18: 393411.
  • 10
    McEwen BS. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol Rev 2007; 87: 873904.
  • 11
    Ulrich-Lai YM, Herman JP. Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci 2009; 10: 397409.
  • 12
    De Kloet ER, Reul JM, Sutanto W. Corticosteroids and the brain. J Steroid Biochem Mol Biol 1990; 37: 387394.
  • 13
    De Kloet ER, Vreugdenhil E, Oitzl MS, Joels M. Brain corticosteroid receptor balance in health and disease. Endocr Rev 1998; 19: 269301.
  • 14
    Herman JP. Regulation of adrenocorticosteroid receptor mRNA expression in the central nervous system. Cell Mol Neurobiol 1993; 13: 349372.
  • 15
    Datson NA, Morsink MC, Meijer OC, De Kloet ER. Central corticosteroid actions: search for gene targets. Eur J Pharmacol 2008; 583: 272289.
  • 16
    Kumar R, Thompson EB. Gene regulation by the glucocorticoid receptor: structure:function relationship. J Steroid Biochem Mol Biol 2005; 94: 383394.
  • 17
    Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM. The nuclear receptor superfamily: the second decade. Cell 1995; 83: 835839.
  • 18
    Nicolaides NC, Galata Z, Kino T, Chrousos GP, Charmandari E. The human glucocorticoid receptor: molecular basis of biologic function. Steroids 2010; 75: 112.
  • 19
    Evanson NK, Herman JP, Sakai RR, Krause EG. Nongenomic actions of adrenal steroids in the central nervous system. J Neuroendocrinol 2010; 22: 846861.
  • 20
    Karst H, Berger S, Turiault M, Tronche F, Schutz G, Joels M. Mineralocorticoid receptors are indispensable for nongenomic modulation of hippocampal glutamate transmission by corticosterone. Proc Natl Acad Sci USA 2005; 102: 1920419207.
  • 21
    Spiga F, Harrison LR, Wood SA, Atkinson HC, MacSweeney CP, Thomson F, Craighead M, Grassie M, Lightman SL. Effect of the glucocorticoid receptor antagonist Org 34850 on basal and stress-induced corticosterone secretion. J Neuroendocrinol 2007; 19: 891900.
  • 22
    Windle RJ, Wood SA, Shanks N, Lightman SL, Ingram CD. Ultradian rhythm of basal corticosterone release in the female rat: dynamic interaction with the response to acute stress. Endocrinology 1998; 139: 443450.
  • 23
    Windle RJ, Wood SA, Lightman SL, Ingram CD. The pulsatile characteristics of hypothalamo-pituitary-adrenal activity in female Lewis and Fischer 344 rats and its relationship to differential stress responses. Endocrinology 1998; 139: 40444052.
  • 24
    Henley DE, Leendertz JA, Russell GM, Wood SA, Taheri S, Woltersdorf WW, Lightman SL. Development of an automated blood sampling system for use in humans. J Med Eng Technol 2009; 33: 199208.
  • 25
    Droste SK, De GL, Atkinson HC, Lightman SL, Reul JM, Linthorst AC. Corticosterone levels in the brain show a distinct ultradian rhythm but a delayed response to forced swim stress. Endocrinology 2008; 149: 32443253.
  • 26
    Droste SK, De GL, Lightman SL, Reul JM, Linthorst AC. The ultradian and circadian rhythms of free corticosterone in the brain are not affected by gender: an in vivo microdialysis study in Wistar rats. J Neuroendocrinol 2009; 21: 132140.
  • 27
    Weitzman ED, Fukushima D, Nogeire C, Roffwarg H, Gallagher TF, Hellman L. Twenty-four hour pattern of the episodic secretion of cortisol in normal subjects. J Clin Endocrinol Metab 1971; 33: 1422.
  • 28
    Dallman MF, Engeland WC, Rose JC, Wilkinson CW, Shinsako J, Siedenburg F. Nycthemeral rhythm in adrenal responsiveness to ACTH. Am J Physiol 1978; 235: R210R218.
  • 29
    Iranmanesh A, Lizarralde G, Johnson ML, Veldhuis JD. Circadian, ultradian, and episodic release of beta-endorphin in men, and its temporal coupling with cortisol. J Clin Endocrinol Metab 1989; 68: 10191026.
  • 30
    Jasper MS, Engeland WC. Synchronous ultradian rhythms in adrenocortical secretion detected by microdialysis in awake rats. Am J Physiol 1991; 261: R1257R1268.
  • 31
    Liu JH, Kazer RR, Rasmussen DD. Characterization of the twenty-four hour secretion patterns of adrenocorticotropin and cortisol in normal women and patients with Cushing’s disease. J Clin Endocrinol Metab 1987; 64: 10271035.
  • 32
    Veldhuis JD, Iranmanesh A, Lizarralde G, Johnson ML. Amplitude modulation of a burstlike mode of cortisol secretion subserves the circadian glucocorticoid rhythm. Am J Physiol 1989; 257: E6E14.
  • 33
    Veldhuis JD, Iranmanesh A, Johnson ML, Lizarralde G. Amplitude, but not frequency, modulation of adrenocorticotropin secretory bursts gives rise to the nyctohemeral rhythm of the corticotropic axis in man. J Clin Endocrinol Metab 1990; 71: 452463.
  • 34
    Shanks N, Lightman SL. The maternal-neonatal neuro-immune interface: are there long-term implications for inflammatory or stress-related disease? J Clin Invest 2001; 108: 15671573.
  • 35
    Windle RJ, Wood SA, Kershaw YM, Lightman SL, Ingram CD, Harbuz MS. Increased corticosterone pulse frequency during adjuvant-induced arthritis and its relationship to alterations in stress responsiveness. J Neuroendocrinol 2001; 13: 905911.
  • 36
    Lightman SL, Wiles CC, Atkinson HC, Henley DE, Russell GM, Leendertz JA, McKenna MA, Spiga F, Wood SA, Conway-Campbell BL. The significance of glucocorticoid pulsatility. Eur J Pharmacol 2008; 583: 255262.
  • 37
    Young EA, Abelson J, Lightman SL. Cortisol pulsatility and its role in stress regulation and health. Front Neuroendocrinol 2004; 25: 6976.
  • 38
    Stavreva DA, Wiench M, John S, Conway-Campbell BL, McKenna MA, Pooley JR, Johnson TA, Voss TC, Lightman SL, Hager GL. Ultradian hormone stimulation induces glucocorticoid receptor-mediated pulses of gene transcription. Nat Cell Biol 2009; 11: 10931102.
  • 39
    Balsalobre A, Brown SA, Marcacci L, Tronche F, Kellendonk C, Reichardt HM, Schutz G, Schibler U. Resetting of circadian time in peripheral tissues by glucocorticoid signaling. Science 2000; 289: 23442347.
  • 40
    Reddy AB, Maywood ES, Karp NA, King VM, Inoue Y, Gonzalez FJ, Lilley KS, Kyriacou CP, Hastings MH. Glucocorticoid signaling synchronizes the liver circadian transcriptome. Hepatology 2007; 45: 14781488.
  • 41
    Buijs RM, Kalsbeek A, Van Der Woude TP, Van Heerikhuize JJ, Shinn S. Suprachiasmatic nucleus lesion increases corticosterone secretion. Am J Physiol 1993; 264: R1186R1192.
  • 42
    Ulrich-Lai YM, Arnhold MM, Engeland WC. Adrenal splanchnic innervation contributes to the diurnal rhythm of plasma corticosterone in rats by modulating adrenal sensitivity to ACTH. Am J Physiol Regul Integr Comp Physiol 2006; 290: R1128R1135.
  • 43
    Abe K, Kroning J, Greer MA, Critchlow V. Effects of destruction of the suprachiasmatic nuclei on the circadian rhythms in plasma corticosterone, body temperature, feeding and plasma thyrotropin. Neuroendocrinology 1979; 29: 119131.
  • 44
    Moore RY, Eichler VB. Loss of a circadian adrenal corticosterone rhythm following suprachiasmatic lesions in the rat. Brain Res 1972; 42: 201206.
  • 45
    Sage D, Maurel D, Bosler O. Involvement of the suprachiasmatic nucleus in diurnal ACTH and corticosterone responsiveness to stress. Am J Physiol Endocrinol Metab 2001; 280: E260E269.
  • 46
    Reppert SM, Weaver DR. Coordination of circadian timing in mammals. Nature 2002; 418: 935941.
  • 47
    Plotsky PM. Pathways to the secretion of adrenocorticotropin: a view from the portal. J Neuroendocrinol 1991; 3: 19.
  • 48
    Engler D, Redei E, Kola I. The corticotropin-release inhibitory factor hypothesis: a review of the evidence for the existence of inhibitory as well as stimulatory hypophysiotropic regulation of adrenocorticotropin secretion and biosynthesis. Endocr Rev 1999; 20: 460500.
  • 49
    Liu JP, Robinson PJ, Funder JW, Engler D. The biosynthesis and secretion of adrenocorticotropin by the ovine anterior pituitary is predominantly regulated by arginine vasopressin (AVP). Evidence that protein kinase C mediates the action of AVP. J Biol Chem 1990; 265: 1413614142.
  • 50
    Ixart G, Barbanel G, Nouguier-Soule J, Assenmacher I. A quantitative study of the pulsatile parameters of CRH-41 secretion in unanesthetized free-moving rats. Exp Brain Res 1991; 87: 153158.
  • 51
    Ixart G, Siaud P, Barbanel G, Mekaouche M, Givalois L, Assenmacher I. Circadian variations in the amplitude of corticotropin-releasing hormone 41 (CRH41) episodic release measured in vivo in male rats: correlations with diurnal fluctuations in hypothalamic and median eminence CRH41 contents. J Biol Rhythms 1993; 8: 297309.
  • 52
    Caraty A, Grino M, Locatelli A, Oliver C. Secretion of corticotropin releasing factor (CRF) and vasopressin (AVP) into the hypophysial portal blood of conscious, unrestrained rams. Biochem Biophys Res Commun 1988; 155: 841849.
  • 53
    Redekopp C, Irvine CH, Donald RA, Livesey JH, Sadler W, Nicholls MG, Alexander SL, Evans MJ. Spontaneous and stimulated adrenocorticotropin and vasopressin pulsatile secretion in the pituitary venous effluent of the horse. Endocrinology 1986; 118: 14101416.
  • 54
    Engler D, Pham T, Fullerton MJ, Ooi G, Funder JW, Clarke IJ. Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. I. Effect of an audiovisual stimulus and insulin-induced hypoglycemia. Neuroendocrinology 1989; 49: 367381.
  • 55
    Wilson RC, Kesner JS, Kaufman JM, Uemura T, Akema T, Knobil E. Central electrophysiologic correlates of pulsatile luteinizing hormone secretion in the rhesus monkey. Neuroendocrinology 1984; 39: 256260.
  • 56
    Carnes M, Lent S, Feyzi J, Hazel D. Plasma adrenocorticotropic hormone in the rat demonstrates three different rhythms within 24 h. Neuroendocrinology 1989; 50: 1725.
  • 57
    Carnes M, Lent SJ, Goodman B, Mueller C, Saydoff J, Erisman S. Effects of immunoneutralization of corticotropin-releasing hormone on ultradian rhythms of plasma adrenocorticotropin. Endocrinology 1990; 126: 19041913.
  • 58
    Antoni FA. Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age. Front Neuroendocrinol 1993; 14: 76122.
  • 59
    Ixart G, Siaud P, Mekaouche M, Barbanel G, Givalois L, Assenmacher I. Short-term but not long-term adrenalectomy modulates amplitude and frequency of the CRH41 episodic release in push-pull cannulated median eminence of free-moving rats. Brain Res 1994; 658: 185191.
  • 60
    Engler D, Pham T, Liu JP, Fullerton MJ, Clarke IJ, Funder JW. Studies of the regulation of the hypothalamic-pituitary-adrenal axis in sheep with hypothalamic-pituitary disconnection. II. Evidence for in vivo ultradian hypersecretion of proopiomelanocortin peptides by the isolated anterior and intermediate pituitary. Endocrinology 1990; 127: 19561966.
  • 61
    Glass L, Mackey MC. From Clocks to Chaos: The Rhythms of Life. Princeton, NJ: Princeton University Press, 1988.
  • 62
    Woods NM, Cuthbertson KS, Cobbold PH. Repetitive transient rises in cytoplasmic free calcium in hormone-stimulated hepatocytes. Nature 1986; 319: 600602.
  • 63
    Goldbeter A. Computational approaches to cellular rhythms. Nature 2002; 420: 238245.
  • 64
    Hastings MH, Reddy AB, Maywood ES. A clockwork web: circadian timing in brain and periphery, in health and disease. Nat Rev Neurosci 2003; 4: 649661.
  • 65
    Hirata H, Yoshiura S, Ohtsuka T, Bessho Y, Harada T, Yoshikawa K, Kageyama R. Oscillatory expression of the bHLH factor Hes1 regulated by a negative feedback loop. Science 2002; 298: 840843.
  • 66
    Dallman MF, Akana SF, Cascio CS, Darlington DN, Jacobson L, Levin N. Regulation of ACTH secretion: variations on a theme of B. Recent Prog Horm Res 1987; 43: 113173.
  • 67
    Jones MT, Hillhouse EW, Burden JL. Dynamics and mechanics of corticosteroid feedback at the hypothalamus and anterior pituitary gland. J Endocrinol 1977; 73: 405417.
  • 68
    Keller-Wood ME, Dallman MF. Corticosteroid inhibition of ACTH secretion. Endocr Rev 1984; 5: 124.
  • 69
    Russell GM, Henley DE, Leendertz J, Douthwaite JA, Wood SA, Stevens A, Woltersdorf WW, Peeters BW, Ruigt GS, White A, Veldhuis JD, Lightman SL. Rapid glucocorticoid receptor-mediated inhibition of hypothalamic-pituitary-adrenal ultradian activity in healthy males. J Neurosci 2010; 30: 61066115.
  • 70
    Bairagi N, Chatterjee S, Chattopadhyay J. Variability in the secretion of corticotropin-releasing hormone, adrenocorticotropic hormone and cortisol and understandability of the hypothalamic-pituitary-adrenal axis dynamics – a mathematical study based on clinical evidence. Math Med Biol 2008; 25: 3763.
  • 71
    Jelic S, Cupic Z, Kolar-Anic L. Mathematical modeling of the hypothalamic-pituitary-adrenal system activity. Math Biosci 2005; 197: 173187.
  • 72
    Lenbury Y, Pornsawad P. A delay-differential equation model of the feedback-controlled hypothalamus-pituitary-adrenal axis in humans. Math Med Biol 2005; 22: 1533.
  • 73
    Mershon JL, Sehlhorst CS, Rebar RW, Liu JH. Evidence of a corticotropin-releasing hormone pulse generator in the macaque hypothalamus. Endocrinology 1992; 130: 29912996.
  • 74
    Gupta S, Aslakson E, Gurbaxani BM, Vernon SD. Inclusion of the glucocorticoid receptor in a hypothalamic pituitary adrenal axis model reveals bistability. Theor Biol Med Model 2007; 4: 8.
  • 75
    Papaikonomou E. Rat adrenocortical dynamics. J Physiol 1977; 265: 119131.
  • 76
    Walker JJ, Terry JR, Lightman SL. Origin of ultradian pulsatility in the hypothalamic-pituitary-adrenal axis. Proc R Soc B Biol Sci 2010; 277: 16271633.
  • 77
    Conway-Campbell BL, Sarabdjitsingh RA, McKenna MA, Pooley JR, Kershaw YM, Meijer OC, De Kloet ER, Lightman SL. Glucocorticoid ultradian rhythmicity directs cyclical gene pulsing of the clock gene period 1 in rat hippocampus. J Neuroendocrinol 2010; 22: 10931100.
  • 78
    Burger LL, Haisenleder DJ, Dalkin AC, Marshall JC. Regulation of gonadotropin subunit gene transcription. J Mol Endocrinol 2004; 33: 559584.
  • 79
    Millar RP, Lu ZL, Pawson AJ, Flanagan CA, Morgan K, Maudsley SR. Gonadotropin-releasing hormone receptors. Endocr Rev 2004; 25: 235275.
  • 80
    Naor Z. Signaling by G-protein-coupled receptor (GPCR): studies on the GnRH receptor. Front Neuroendocrinol 2009; 30: 1029.
  • 81
    Bertram R, Li YX. A mathematical model for the actions of activin, inhibin, and follistatin on pituitary gonadotrophs. Bull Math Biol 2008; 70: 22112228.
  • 82
    Tsutsumi R, Webster NJ. GnRH pulsatility, the pituitary response and reproductive dysfunction. Endocr J 2009; 56: 729737.
  • 83
    Crowley WF Jr, Filicori M, Spratt DI, Santoro NF. The physiology of gonadotropin-releasing hormone (GnRH) secretion in men and women. Recent Prog Horm Res 1985; 41: 473531.
  • 84
    Ferris HA, Shupnik MA. Mechanisms for pulsatile regulation of the gonadotropin subunit genes by GNRH1. Biol Reprod 2006; 74: 993998.
  • 85
    Belchetz PE, Plant TM, Nakai Y, Keogh EJ, Knobil E. Hypophysial responses to continuous and intermittent delivery of hypopthalamic gonadotropin-releasing hormone. Science 1978; 202: 631633.
  • 86
    Sisk CL, Foster DL. The neural basis of puberty and adolescence. Nat Neurosci 2004; 7: 10401047.
  • 87
    Schally AV. Luteinizing hormone-releasing hormone analogs: their impact on the control of tumorigenesis. Peptides 1999; 20: 12471262.
  • 88
    Bedecarrats GY, Kaiser UB. Differential regulation of gonadotropin subunit gene promoter activity by pulsatile gonadotropin-releasing hormone (GnRH) in perifused L beta T2 cells: role of GnRH receptor concentration. Endocrinology 2003; 144: 18021811.
  • 89
    Dalkin AC, Haisenleder DJ, Ortolano GA, Ellis TR, Marshall JC. The frequency of gonadotropin-releasing-hormone stimulation differentially regulates gonadotropin subunit messenger ribonucleic acid expression. Endocrinology 1989; 125: 917924.
  • 90
    Haisenleder DJ, Dalkin AC, Ortolano GA, Marshall JC, Shupnik MA. A pulsatile gonadotropin-releasing hormone stimulus is required to increase transcription of the gonadotropin subunit genes: evidence for differential regulation of transcription by pulse frequency in vivo. Endocrinology 1991; 128: 509517.
  • 91
    Kaiser UB, Jakubowiak A, Steinberger A, Chin WW. Regulation of rat pituitary gonadotropin-releasing hormone receptor mRNA levels in vivo and in vitro. Endocrinology 1993; 133: 931934.
  • 92
    Shupnik MA. Effects of gonadotropin-releasing hormone on rat gonadotropin gene transcription in vitro: requirement for pulsatile administration for luteinizing hormone-beta gene stimulation. Mol Endocrinol 1990; 4: 14441450.
  • 93
    Weiss J, Jameson JL, Burrin JM, Crowley WF Jr. Divergent responses of gonadotropin subunit messenger RNAs to continuous versus pulsatile gonadotropin-releasing hormone in vitro. Mol Endocrinol 1990; 4: 557564.
  • 94
    Yasin M, Dalkin AC, Haisenleder DJ, Kerrigan JR, Marshall JC. Gonadotropin-releasing hormone (GnRH) pulse pattern regulates GnRH receptor gene expression: augmentation by estradiol. Endocrinology 1995; 136: 15591564.
  • 95
    Heinze K, Keener RW, Midgley AR Jr. A mathematical model of luteinizing hormone release from ovine pituitary cells in perifusion. Am J Physiol 1998; 275: E1061E1071.
  • 96
    Krakauer DC, Page KM, Sealfon S. Module dynamics of the GnRH signal transduction network. J Theor Biol 2002; 218: 457470.
  • 97
    Li Y, Goldbeter A. Frequency specificity in intercellular communication. Influence of patterns of periodic signaling on target cell responsiveness. Biophys J 1989; 55: 125145.
  • 98
    Lim S, Pnueli L, Tan JH, Naor Z, Rajagopal G, Melamed P. Negative feedback governs gonadotrope frequency-decoding of gonadotropin releasing hormone pulse-frequency. PLoS ONE 2009; 4: e7244.
  • 99
    Ruf F, Park MJ, Hayot F, Lin G, Roysam B, Ge Y, Sealfon SC. Mixed analog/digital gonadotrope biosynthetic response to gonadotropin-releasing hormone. J Biol Chem 2006; 281: 3096730978.
  • 100
    Sealfon SC, Weinstein H, Millar RP. Molecular mechanisms of ligand interaction with the gonadotropin-releasing hormone receptor. Endocr Rev 1997; 18: 180205.
  • 101
    Washington TM, Blum JJ, Reed MC, Conn PM. A mathematical model for LH release in response to continuous and pulsatile exposure of gonadotrophs to GnRH. Theor Biol Med Model 2004; 1: 9.
  • 102
    Heding A, Vrecl M, Hanyaloglu AC, Sellar R, Taylor PL, Eidne KA. The rat gonadotropin-releasing hormone receptor internalizes via a beta-arrestin-independent, but dynamin-dependent, pathway: addition of a carboxyl-terminal tail confers beta-arrestin dependency. Endocrinology 2000; 141: 299306.
  • 103
    Hislop JN, Caunt CJ, Sedgley KR, Kelly E, Mundell S, Green LD, McArdle CA. Internalization of gonadotropin-releasing hormone receptors (GnRHRs): does arrestin binding to the C-terminal tail target GnRHRs for dynamin-dependent internalization? J Mol Endocrinol 2005; 35: 177189.
  • 104
    Willars GB, Heding A, Vrecl M, Sellar R, Blomenrohr M, Nahorski SR, Eidne KA. Lack of a C-terminal tail in the mammalian gonadotropin-releasing hormone receptor confers resistance to agonist-dependent phosphorylation and rapid desensitization. J Biol Chem 1999; 274: 3014630153.
  • 105
    Lawson MA, Tsutsumi R, Zhang H, Talukdar I, Butler BK, Santos SJ, Mellon PL, Webster NJ. Pulse sensitivity of the luteinizing hormone beta promoter is determined by a negative feedback loop Involving early growth response-1 and Ngfi-A binding protein 1 and 2. Mol Endocrinol 2007; 21: 11751191.
  • 106
    Ciccone NA, Xu S, Lacza CT, Carroll RS, Kaiser UB. Frequency-dependent regulation of follicle-stimulating hormone beta by pulsatile gonadotropin-releasing hormone is mediated by functional antagonism of bZIP transcription factors. Mol Cell Biol 2010; 30: 10281040.
  • 107
    Burger LL, Haisenleder DJ, Aylor KW, Marshall JC. Regulation of intracellular signaling cascades by GNRH pulse frequency in the rat pituitary: roles for CaMK II, ERK, and JNK activation. Biol Reprod 2008; 79: 947953.
  • 108
    Haisenleder DJ, Ferris HA, Shupnik MA. The calcium component of gonadotropin-releasing hormone-stimulated luteinizing hormone subunit gene transcription is mediated by calcium/calmodulin-dependent protein kinase type II. Endocrinology 2003; 144: 24092416.
  • 109
    Haisenleder DJ, Burger LL, Aylor KW, Dalkin AC, Marshall JC. Gonadotropin-releasing hormone stimulation of gonadotropin subunit transcription: evidence for the involvement of calcium/calmodulin-dependent kinase II (Ca/CAMK II) activation in rat pituitaries. Endocrinology 2003; 144: 27682774.
  • 110
    Berridge MJ. Cell Signalling Biology. London: Portland Press Ltd, 2008. .
  • 111
    Craske M, Takeo T, Gerasimenko O, Vaillant C, Torok K, Petersen OH, Tepikin AV. Hormone-induced secretory and nuclear translocation of calmodulin: oscillations of calmodulin concentration with the nucleus as an integrator. Proc Natl Acad Sci USA 1999; 96: 44264431.
  • 112
    De Koninck P, Schulman H. Sensitivity of CaM kinase II to the frequency of Ca2+ oscillations. Science 1998; 279: 227230.
  • 113
    Mermelstein PG, Deisseroth K, Dasgupta N, Isaksen AL, Tsien RW. Calmodulin priming: nuclear translocation of a calmodulin complex and the memory of prior neuronal activity. Proc Natl Acad Sci USA 2001; 98: 1534215347.
  • 114
    Gardner S, Pawson AJ. Emerging targets of the GnRH receptor: novel interactions with Wnt signalling mediators. Neuroendocrinology 2009; 89: 241251.
  • 115
    Lim S, Luo M, Koh M, Yang M, Bin Abdul Kadir MN, Tan JH, Ye Z, Wang W, Melamed P. Distinct mechanisms involving diverse histone deacetylases repress expression of the two gonadotropin beta-subunit genes in immature gonadotropes, and their actions are overcome by gonadotropin-releasing hormone. Mol Cell Biol 2007; 27: 41054120.
  • 116
    Oosterom J, Van Doornmalen EJ, Lobregt S, Blomenrohr M, Zaman GJ. High-throughput screening using beta-lactamase reporter-gene technology for identification of low-molecular-weight antagonists of the human gonadotropin releasing hormone receptor. Assay Drug Dev Technol 2005; 3: 143154.
  • 117
    Berridge MJ. Remodelling Ca2+ signalling systems and cardiac hypertrophy. Biochem Soc Trans 2006; 34: 228231.
  • 118
    Dolmetsch RE, Xu K, Lewis RS. Calcium oscillations increase the efficiency and specificity of gene expression. Nature 1998; 392: 933936.
  • 119
    Li W, Llopis J, Whitney M, Zlokarnik G, Tsien RY. Cell-permeant caged InsP3 ester shows that Ca2+ spike frequency can optimize gene expression. Nature 1998; 392: 936941.
  • 120
    Tomida T, Hirose K, Takizawa A, Shibasaki F, Iino M. NFAT functions as a working memory of Ca2+ signals in decoding Ca2+ oscillation. EMBO J 2003; 22: 38253832.
  • 121
    Armstrong SP, Caunt CJ, Fowkes RC, Tsaneva-Atanasova K, McArdle CA. Pulsatile and sustained gonadotropin-releasing hormone (GnRH) receptor signaling: does the Ca2+/NFAT signaling pathway decode GnRH pulse frequency? J Biol Chem 2009; 284: 3574635757.
  • 122
    Caunt CJ, Finch AR, Sedgley KR, McArdle CA. Seven-transmembrane receptor signalling and ERK compartmentalization. Trends Endocrinol Metab 2006; 17: 276283.
  • 123
    Caunt CJ, Finch AR, Sedgley KR, McArdle CA. GnRH receptor signalling to ERK: kinetics and compartmentalization. Trends Endocrinol Metab 2006; 17: 308313.
  • 124
    Mitchell R, Sim PJ, Leslie T, Johnson MS, Thomson FJ. Activation of MAP kinase associated with the priming effect of LHRH. J Endocrinol 1994; 140: R15R18.
  • 125
    Roberson MS, Misra-Press A, Laurance ME, Stork PJ, Maurer RA. A role for mitogen-activated protein kinase in mediating activation of the glycoprotein hormone alpha-subunit promoter by gonadotropin-releasing hormone. Mol Cell Biol 1995; 15: 35313539.
  • 126
    Sim P, Mitchell R, Thorfinn L. Activation of MAP kinase in alpha T3-1 cells by luteinising hormone-releasing hormone. Biochem Soc Trans 1993; 21: 357S.
  • 127
    Haisenleder DJ, Cox ME, Parsons SJ, Marshall JC. Gonadotropin-releasing hormone pulses are required to maintain activation of mitogen-activated protein kinase: role in stimulation of gonadotrope gene expression. Endocrinology 1998; 139: 31043111.
  • 128
    Kanasaki H, Bedecarrats GY, Kam KY, Xu S, Kaiser UB. Gonadotropin-releasing hormone pulse frequency-dependent activation of extracellular signal-regulated kinase pathways in perifused LbetaT2 cells. Endocrinology 2005; 146: 55035513.
  • 129
    Bliss SP, Miller A, Navratil AM, Xie J, McDonough SP, Fisher PJ, Landreth GE, Roberson MS. ERK signaling in the pituitary is required for female but not male fertility. Mol Endocrinol 2009; 23: 10921101.
  • 130
    Cullen PJ, Lockyer PJ. Integration of calcium and Ras signalling. Nat Rev Mol Cell Biol 2002; 3: 339348.
  • 131
    Durham PL, Russo AF. Differential regulation of mitogen-activated protein kinase-responsive genes by the duration of a calcium signal. Mol Endocrinol 2000; 14: 15701582.
  • 132
    Kupzig S, Walker SA, Cullen PJ. The frequencies of calcium oscillations are optimized for efficient calcium-mediated activation of Ras and the ERK/MAPK cascade. Proc Natl Acad Sci USA 2005; 102: 75777582.
  • 133
    Armstrong SP, Caunt CJ, Fowkes RC, Tsaneva-Atanasova K, McArdle CA. Pulsatile and sustained gonadotropin-releasing hormone (GnRH) receptor signaling: does the ERK signaling pathway decode GnRH pulse frequency? J Biol Chem 2010; 285: 243602471.
  • 134
    Caunt CJ, Armstrong SP, Rivers CA, Norman MR, McArdle CA. Spatiotemporal regulation of ERK2 by dual specificity phosphatases. J Biol Chem 2008; 283: 2661226623.
  • 135
    Caunt CJ, Rivers CA, Conway-Campbell BL, Norman MR, McArdle CA. Epidermal growth factor receptor and protein kinase C signaling to ERK2: spatiotemporal regulation of ERK2 by dual specificity phosphatases. J Biol Chem 2008; 283: 62416252.
  • 136
    Armstrong SP, Caunt CJ, McArdle CA. Gonadotropin-releasing hormone and protein kinase C signaling to ERK: spatiotemporal regulation of ERK by docking domains and dual-specificity phosphatases. Mol Endocrinol 2009; 23: 510519.
  • 137
    Zhang T, Mulvaney JM, Roberson MS. Activation of mitogen-activated protein kinase phosphatase 2 by gonadotropin-releasing hormone. Mol Cell Endocrinol 2001; 172: 7989.
  • 138
    Zhang T, Roberson MS. Role of MAP kinase phosphatases in GnRH-dependent activation of MAP kinases. J Mol Endocrinol 2006; 36: 4150.
  • 139
    Finch AR, Caunt CJ, Armstrong SP, McArdle CA. Agonist-induced internalization and downregulation of gonadotropin-releasing hormone receptors. Am J Physiol Cell Physiol 2009; 297: C591C600.